C100H106N36O4 — CID 157290415
N-[(1,5-dimethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;N-ethyl-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-[(1-methylpyrazol-4-yl)methyl]-1H-indole-2-carboxamide;N-[(1-ethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-(1-propan-2-yl-6,7-dihydro-4H-pyrazolo[4,5-c]pyridin-5-yl)methanone (PubChem CID 157290415) has the molecular formula C100H106N36O4 and a molecular weight of 1876.20 g/mol. Its IUPAC name is N-[(1,5-dimethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;N-ethyl-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-[(1-methylpyrazol-4-yl)methyl]-1H-indole-2-carboxamide;N-[(1-ethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-(1-propan-2-yl-6,7-dihydro-4H-pyrazolo[4,5-c]pyridin-5-yl)methanone.
| Compound Name | N-[(1,5-dimethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;N-ethyl-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-[(1-methylpyrazol-4-yl)methyl]-1H-indole-2-carboxamide;N-[(1-ethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-(1-propan-2-yl-6,7-dihydro-4H-pyrazolo[4,5-c]pyridin-5-yl)methanone |
|---|---|
| PubChem CID | 157290415 |
| Molecular Formula | C100H106N36O4 |
| Molecular Weight | 1876.20 g/mol |
| Exact Mass | 1874.92 |
| IUPAC Name | N-[(1,5-dimethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;N-ethyl-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-[(1-methylpyrazol-4-yl)methyl]-1H-indole-2-carboxamide;N-[(1-ethylpyrazol-4-yl)methyl]-7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-(1-propan-2-yl-6,7-dihydro-4H-pyrazolo[4,5-c]pyridin-5-yl)methanone |
| SMILES | CCN(Cc1cnn(C)c1)C(=O)c1cc2cc(Nc3nccc(-c4cn(C)cn4)n3)cc(C)c2[nH]1.CCn1cc(CNC(=O)c2cc3cc(Nc4nccc(-c5cn(C)cn5)n4)cc(C)c3[nH]2)cn1.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N3CCc4c(cnn4C(C)C)C3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3cnn(C)c3C)[nH]c12 |
| InChI | InChI=1S/C27H29N9O.C25H27N9O.2C24H25N9O/c1-16(2)36-24-6-8-35(13-19(24)12-30-36)26(37)22-11-18-10-20(9-17(3)25(18)32-22)31-27-28-7-5-21(33-27)23-14-34(4)15-29-23;1-5-34(13-17-11-28-33(4)12-17)24(35)21-10-18-9-19(8-16(2)23(18)30-21)29-25-26-7-6-20(31-25)22-14-32(3)15-27-22;1-14-7-18(29-24-25-6-5-19(31-24)21-12-32(3)13-27-21)8-16-9-20(30-22(14)16)23(34)26-10-17-11-28-33(4)15(17)2;1-4-33-12-16(11-28-33)10-26-23(34)20-9-17-8-18(7-15(2)22(17)30-20)29-24-25-6-5-19(31-24)21-13-32(3)14-27-21/h5,7,9-12,14-16,32H,6,8,13H2,1-4H3,(H,28,31,33);6-12,14-15,30H,5,13H2,1-4H3,(H,26,29,31);5-9,11-13,30H,10H2,1-4H3,(H,26,34)(H,25,29,31);5-9,11-14,30H,4,10H2,1-3H3,(H,26,34)(H,25,29,31) |
| InChIKey | BASTWDSHEKHXCT-UHFFFAOYSA-N |
| XLogP | 15.13 |
| TPSA | 455.78 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 140 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1876.20 |
| LogP ≤ 5 | 15.13 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 32 |